Novocure announced that the final patient has enrolled in the pivotal METIS study evaluating the efficacy of Tumor Treating Fields, or TTFields, therapy following stereotactic radiosurgery for treatment of patients with brain metastases resulting from non-small cell lung cancer.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVCR: